Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bacterial Toxins | 1 | 2017 | 185 | 0.62 | Why? |
| Clostridium Infections | 3 | 2018 | 595 | 0.61 | Why? |
| Adenovirus Infections, Human | 1 | 2017 | 145 | 0.60 | Why? |
| Gastroenteritis | 2 | 2018 | 489 | 0.60 | Why? |
| Adenoviruses, Human | 1 | 2017 | 195 | 0.59 | Why? |
| Molecular Diagnostic Techniques | 6 | 2020 | 4239 | 0.56 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.54 | Why? |
| Enterobius | 1 | 2011 | 2 | 0.48 | Why? |
| Enterobiasis | 1 | 2011 | 4 | 0.48 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.46 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.45 | Why? |
| Viruses | 2 | 2018 | 2238 | 0.45 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.42 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.38 | Why? |
| Virology | 1 | 2012 | 489 | 0.35 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.32 | Why? |
| Neoplasms | 7 | 2021 | 17251 | 0.31 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2018 | 449 | 0.31 | Why? |
| Polymerase Chain Reaction | 3 | 2020 | 6740 | 0.28 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.27 | Why? |
| Diagnostic Tests, Routine | 4 | 2021 | 2643 | 0.27 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.26 | Why? |
| Tuberculosis | 2 | 2018 | 2895 | 0.24 | Why? |
| Eye Diseases | 1 | 2011 | 1150 | 0.20 | Why? |
| Adoptive Transfer | 1 | 2020 | 250 | 0.20 | Why? |
| Bacteriological Techniques | 2 | 2018 | 239 | 0.19 | Why? |
| Nocardia | 1 | 2018 | 21 | 0.19 | Why? |
| Entamoeba histolytica | 1 | 2018 | 22 | 0.19 | Why? |
| Histological Techniques | 1 | 2018 | 35 | 0.19 | Why? |
| Salmonella | 1 | 2018 | 58 | 0.18 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.18 | Why? |
| Nontuberculous Mycobacteria | 1 | 2018 | 114 | 0.17 | Why? |
| Pathology, Molecular | 1 | 2020 | 343 | 0.16 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.16 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.15 | Why? |
| Mouth | 1 | 2020 | 622 | 0.15 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.15 | Why? |
| Immunoenzyme Techniques | 1 | 2017 | 448 | 0.15 | Why? |
| Virus Diseases | 1 | 2012 | 3779 | 0.14 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Nose | 1 | 2020 | 1093 | 0.13 | Why? |
| Invasive Fungal Infections | 1 | 2018 | 274 | 0.13 | Why? |
| Tertiary Healthcare | 1 | 2017 | 616 | 0.13 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.12 | Why? |
| Immunocompromised Host | 2 | 2018 | 5150 | 0.11 | Why? |
| Influenza B virus | 1 | 2017 | 815 | 0.11 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.10 | Why? |
| Illinois | 1 | 2011 | 468 | 0.10 | Why? |
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 2426 | 0.10 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.10 | Why? |
| Nose Diseases | 1 | 2011 | 139 | 0.10 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.10 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.10 | Why? |
| Brain Diseases | 1 | 2021 | 1463 | 0.09 | Why? |
| Cancer Care Facilities | 2 | 2018 | 1190 | 0.09 | Why? |
| Microscopy | 1 | 2011 | 414 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| Feces | 2 | 2017 | 4235 | 0.08 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| Influenza A virus | 1 | 2017 | 2234 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Female | 10 | 2021 | 380317 | 0.06 | Why? |
| Cerebrospinal Fluid Proteins | 1 | 2021 | 38 | 0.06 | Why? |
| Medical Oncology | 1 | 2018 | 3826 | 0.06 | Why? |
| Autografts | 1 | 2020 | 78 | 0.06 | Why? |
| New York City | 3 | 2021 | 7432 | 0.05 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.05 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Nocardia Infections | 1 | 2018 | 37 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| United States | 3 | 2020 | 46150 | 0.04 | Why? |
| Allografts | 1 | 2020 | 761 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Coinfection | 1 | 2016 | 6820 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
| Adult | 6 | 2020 | 244371 | 0.04 | Why? |
| Culture Media | 1 | 2018 | 366 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.04 | Why? |
| Child | 2 | 2017 | 70012 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Cross Infection | 1 | 2016 | 8675 | 0.03 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.03 | Why? |
| Policy | 1 | 2021 | 1372 | 0.03 | Why? |
| Neuroimaging | 1 | 2021 | 1106 | 0.03 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.03 | Why? |
| Infant | 1 | 2012 | 30274 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2018 | 2149 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Recurrence | 1 | 2016 | 3675 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2018 | 3388 | 0.02 | Why? |
| Brain | 1 | 2021 | 5133 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Animals | 1 | 2011 | 78931 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.01 | Why? |
Babady's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(162)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_